Symrise H1 2026: €2.54bn sales as Q2 organic growth accelerates

H1 performance

Symrise reported H1 2026 sales of €2,539 million and organic sales growth of 2.0% for the period, with growth accelerating to 4.5% in Q2. Adjusted EBITDA for H1 was €553 million, corresponding to an adjusted EBITDA margin of 21.8%. Adjusted Business Free Cash Flow rose to €347 million (13.7% margin), supported by profitable sales growth and efficiency measures, while earnings were partly offset by investments in the ONE SYM transformation and higher logistics costs linked to geopolitical tensions in the Middle East.

Segment highlights

Taste, Nutrition & Health delivered Q2 organic growth of 4.9% with reported Q2 sales of €782 million and H1 reported sales of €1,530 million; H1 adjusted EBITDA was €375 million with a 24.5% margin. Food & Beverage showed mid- to high-single-digit growth across Savory, Naturals and Sweet, while Pet Food saw a slight decline amid nutrition price normalization.

Scent & Care posted Q2 organic growth of 3.8% with Q2 reported sales of €509 million and H1 reported sales of €1,009 million; adjusted EBITDA was €178 million (17.7% margin). Fragrance saw mixed trends—Consumer Fragrance grew strongly while Fine Fragrance declined on high comparables—Care & Wellness declined slightly, and Aroma Molecules delivered high-single-digit growth with double-digit gains in Specialty Fragrance Ingredients and Menthol.

Strategy and outlook

Symrise submitted a binding offer for Floral Concept to strengthen its position in premium naturals for Fine Fragrance and is accelerating the ONE SYM Transformation to drive commercial excellence, innovation and digitalization while reinvesting efficiency gains into growth. The company reaffirmed its 2026 outlook: organic sales growth of 2–4%, an adjusted EBITDA margin of 21.5–22.5%, and an adjusted Business Free Cash Flow margin above 14%.